SECTION I: RADIATION ONCOLOGY Adaptative Radiation Therapy Low-Dose Radiation Therapy for Benign Musculoskeletal Disorders SECTION II: SURGICAL ONCOLOGY Neoadjuvant Treatment Strategies in Gastrointestinal Stromal Tumors Hepatic Artery Infusion Pump Therapy in Unresectable and Resectable Liver Tumors Contemporary Approaches to Adrenocortical Carcinoma SECTION III: MEDICAL ONCOLOGY State of the Art Therapy for Recurrent or Advanced Head and Neck Cancer Integration of Early Palliative Care in Personalized Cancer Care Treatment Advances in Small Cell Lung Cancer SECTION IV: GYNECOLOGIC ONCOLOGY Emerging Therapeutic Targets for Platinum Resistant Ovarian Cancer Sexual Health Following Diagnosis and Treatment of Gynecologic Cancer SECTION V: PEDIATRIC ONCOLOGY Oncofertility in Pediatric and Adolescent Patients: Current Practice and Future Directions Subsequent Malignant Neoplasms in Childhood Cancer Survivors: Identifying Risks and Screening Recommendations Neurocognitive Late Effects Among Childhood Cancer Survivors: A Holistic Review of Clinical Risk Factors SECTION VI: NEURO-ONCOLOGY Treatment of Isocitrate Dehydrogenase Mutant Gliomas Exosomes in Glioma: Diagnostic and Therapeutic Potentials Maximal Extent of Resection, Including Supramaximal Resection, for Diffuse Gliomas SECTION VII: HEMATOLOGICAL ONCOLOGY Will Triplet Therapy Become Standard of Care in Acute Myeloid Leukemia? Current and Future Approaches for the Treatment of Plasma Cell Leukemia Germline Testing in Hematopoietic Malignancies: Whom to Test, When, How, and Why SECTION VIII: URO-ONCOLOGY Bladder-Sparing Approaches in Muscle Invasive Bladder Cancer Adjuvant Therapy in Renal Cell Carcinoma: Current Landscape and Future Directions Poly-ADP Ribose Polymerase Inhibitors and Combinations in Metastatic Prostate Cancer SECTION IX: GASTROINTESTINAL ONCOLOGY The Potential Role of Circulating Tumor DNA as a Tool in the Management of Gastrointestinal Malignancies How I Treat Advanced Biliary Cancer Disparities Along the Cancer Care Continuum: The Role of Social Drivers of Health on Gastrointestinal Malignancies.